ZYBERNO
Stock Report
Updated Aug 31, 2026

Vivani Medical, Inc. (VANI)

Healthcare • NASDAQ

$1.40

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
10.0/100
POOR BUSINESS
Vivani Medical, Inc. (VANI) scores 10/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-191.1%)
Debt-to-Equity (Solvency Risk):POOR (1.88x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-120.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Vivani Medical, Inc. (VANI) stock report — Zyberno Score 10/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, VANI generated -$25.65M in Owner Earnings. Capital was deployed as follows: $1.17M invested in capital expenditures. Reinvestment rate: -3.7%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.40
Market Cap:$121.93M

Valuation Multiples (2)

P/B Ratio:6.43x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$119.89M

Price Action & Momentum (3)

Momentum Percentile:33 / 100
% of 52-Week High:72.9%
B. Profitability Assessment

Return Metrics (5)

ROA:-70.9%
Reinvestment Rate:-3.7%
Fundamental Growth Rate (g):4.4%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$26.12
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:39.1%
Latest Earnings Filed:2026-08-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.25x
Quick Ratio:3.25x
Cash Ratio:2.99x

Leverage Analysis (3)

Debt To Equity Ttm:1.88x
Debt-to-Equity Ratio:1.88x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:14,976,000.00
Cash And Cash Equivalents:19,894,000.00
Long Term Debt:$16.01M
Net Debt:-$2.04M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $0.00
Linear Growth: -50.0%
📊 Click to view full VANI Revenue analysis & methodology →
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$27.23M

Bottom Line Performance (3)

-$26.31M
Income Before Tax:-$26.61M
Ebitda Ttm:-26,750,000.00

Operating Expenses (5)

Operating Expenses:27,228,000.00
R And D Expense:17,996,000.00
Sga Expense:9,232,000.00
Income Tax Expense:$2.00K
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$41.64M
Current Assets:$21.64M
Ppe Net:2,850,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:22,672,000.00
Current Liabilities:6,659,000.00
Long Term Debt:$16.01M
Short Term Debt:$1.84M

Equity & Capital (3)

Equity:$18.97M
Retained Earnings:-$161.68M
Common Stock:300,000,000.00

Working Capital Items (3)

Accounts Receivable:12,000.00
Inventory:0.00
Accounts Payable:1,195,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:313,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$25.35M-$26.52M

Investment Activities (2)

Investing Cash Flow:-$3.00K
Capital Expenditures Ttm:1,171,000.00

Financing Activities (3)

Financing Cash Flow:$9.71M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:478,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.35
-$0.35
Earnings Per Share Ttm:-$0.30

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.28

Book Value & Capital (2)

Book Value Per Share:$0.22
Cash Per Share:0.23

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:15.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$25.65M

Damodaran Growth Analysis (2)

Reinvestment Rate:-3.7%
Fundamental Growth Rate (g):4.4%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (1)

Book Value Growth Rate (Linear):-39.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:VANI
Company Name:Vivani Medical, Inc.
Sector:Healthcare
Industry:Medical Technology
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:87.09M
Shares Outstanding Basic:87.09M
Shares Outstanding Diluted:87.09M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 18:06:36 UTC
Data Timestamp:2026-08-19T17:05:46.110065
Scroll to Top